<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-67545</identifier>
<setSpec>0210-573X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Objective. To evaluate the treatment and follow-up of pregnant women with HIV-AIDS at the Hospital de León from 1996 to 2006. Material and method. We performed an observational, descriptive, retrospective study. A total of 21,780 births and 18 pregnant women with HIV-AIDS with 21 labors were analyzed. Special emphasis was placed on labor-related variables. Results. The prevalence of HIV infection was 1%. Highly active antiretroviral therapy was used by 47%. Full term pregnancies were achieved in 95%. Cesarean sections were performed in 71.5%. There was one minor congenital malformation. Vertical transmission in pregnant women diagnosed before delivery occurred in 4.7%. Conclusions. The treatment and follow-up provided to pregnant women with HIV-AIDS was adequate and in accordance with the protocols of the Spanish Society of Obstetrics and Gynecology. The incidence of adverse effects and obstetric pathology was not high (AU)</dc:description>
<dc:creator>González-García, C</dc:creator>
<dc:creator>Zornoza-García, V</dc:creator>
<dc:creator>Fernández-Corona, A</dc:creator>
<dc:creator>Luengo-Tabernero, A</dc:creator>
<dc:creator>Ferrero-Viñas, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo. Valoración del tratamiento y seguimiento de la gestante con VIH-sida en el Hospital de León en el período 1996-2006. Material y método. Estudio observacional, descriptivo y retrospectivo. Se analizaron 21.780 nacimientos, 18 gestantes con VIH-sida con 21 partos. Especial hincapié en las variables relativas al momento del parto. Resultados. Prevalencia del VIH-sida del 1&#137;, tratamiento TARGA el 47%, embarazos a término el 95%, cesáreas el 71,5%. Una única malformación congénita menor. Transmisión vertical en gestantes diagnosticadas antes del parto del 4,7%. Conclusiones. La asistencia fue adecuada y acorde con los protocolos de la SEGO. No se observó alta incidencia de efectos adversos ni patología obstétrica (AU)</dc:description>
<dc:source>Clín. investig. ginecol. obstet. (Ed. impr.);35(3): 72-77, mayo 2008. ilus, tab</dc:source>
<dc:identifier>ibc-67545</dc:identifier>
<dc:subject>^d24718^s22012</dc:subject>
<dc:subject>^d11731^s22083</dc:subject>
<dc:subject>^d22261</dc:subject>
<dc:subject>^d24718^s22057</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d29364^s22080</dc:subject>
<dc:subject>^d33075^s22073</dc:subject>
<dc:subject>^d7435</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d13411^s22080</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d11691^s22057</dc:subject>
<dc:subject>^d7926</dc:subject>
<dc:subject>^d7991^s22045</dc:subject>
<dc:subject>^d29399</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d40^s22080</dc:subject>
<dc:subject>^d4920^s22045</dc:subject>
<dc:subject>^d38332^s22073</dc:subject>
<dc:subject>^d11622^s22080</dc:subject>
<dc:subject>^d24718^s22080</dc:subject>
<dc:subject>^d40^s22012</dc:subject>
<dc:subject>^d7922^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>200805</dc:date>
</metadata>
</record>
</ibecs-document>
